01 8ASTRAZENECA AB
01 88895033
01 8Blank
01 8Y
01 82030-10-04
Patent Expiration Date : 2030-10-04
US Patent Number : 8895033
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209210
Patent Use Code : U-3189
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-04
Patent Expiration Date : 2030-10-04
US Patent Number : 8895033
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209210
Patent Use Code : U-2601
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-04
Patent Expiration Date : 2030-10-04
US Patent Number : 8895033
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209210
Patent Use Code : U-3188
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-04
Patent Expiration Date : 2030-10-04
US Patent Number : 8895033
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209210
Patent Use Code : U-2590
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-04
Patent Expiration Date : 2030-10-04
US Patent Number : 8895033
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209210
Patent Use Code : U-3190
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-04
Patent Expiration Date : 2030-10-04
US Patent Number : 8895033
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209210
Patent Use Code : U-2597
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-04
Patent Expiration Date : 2030-10-04
US Patent Number : 8895033
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209210
Patent Use Code : U-2602
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-04
Patent Expiration Date : 2030-10-04
US Patent Number : 8895033
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209210
Patent Use Code : U-2589
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-10-04
